stoxline Quote Chart Rank Option Currency Glossary
  
Alger Mid Cap 40 ETF (FRTY)
20.728  0.068 (0.33%)    12-16 15:59
Open: 20.6
High: 20.74
Volume: 104,430
  
Pre. Close: 20.66
Low: 20.53
Market Cap: 120(M)
Technical analysis
2025-12-16 4:44:04 PM
Short term     
Mid term     
Targets 6-month :  25.66 1-year :  29.97
Resists First :  21.96 Second :  25.66
Pivot price 21.14
Supports First :  20.36 Second :  19.37
MAs MA(5) :  21.04 MA(20) :  20.9
MA(100) :  21.27 MA(250) :  0
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  44 D(3) :  64.4
RSI RSI(14): 43
52-week High :  23.36 Low :  13.56
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ FRTY ] has closed above bottom band by 14.2%. Bollinger Bands are 38.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 20.75 - 20.85 20.85 - 20.96
Low: 20.29 - 20.39 20.39 - 20.5
Close: 20.56 - 20.73 20.73 - 20.9
Company Description

Under normal circumstances, the fund invests at least 80% of its net assets in equity securities of mid-cap companies. Equity securities include common or preferred stocks that are listed on U.S. exchanges. It may invest a significant portion of its assets in the securities of companies conducting business in the information technology and healthcare sectors. The fund is non-diversified.

Headline News

Tue, 09 Dec 2025
(FRTY) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com

Thu, 04 Dec 2025
Worst-Performing Stock ETFs - Morningstar

Tue, 23 Sep 2025
FRTY: Growth-Focused ETF With Ambitious Premise But Questionable Returns (NYSEARCA:FRTY) - Seeking Alpha

Thu, 04 Sep 2025
SPIVA 2025 Mid-Year Report Throws Spotlight on Active SMIDcap Funds - ETF Trends

Thu, 22 May 2025
FRTY: A Focused Mid-Cap Growth ETF Throwing Caution To The Wind - Seeking Alpha

Tue, 07 Jan 2025
New ETF From Alger Focuses on Innovation - ETF Trends

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Financial Services
Industry:
Asset Management
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android